Advertisement World Vaccine Congress - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

World Vaccine Congress

Logo
WHITE PAPERS
PRODUCTS & SERVICES
Quick Contact World Vaccine Congress
LATEST PRESS RELEASES


LATEST VIDEOS

World Vaccine Congress

The World Vaccine Congress Washington is a series of conferences and an exhibition designed to promote research, development and strategic partnerships for the global vaccine industry.

The World Vaccine Congress Washington is a series of conferences and an exhibition designed to promote research, development and strategic partnerships for the global vaccine industry.

Taking place 6-9 April in Washington, US, the event has grown over the past 19 years into the world’s biggest and most established global vaccine event with more than 350 speakers.

The event is expected to attract more than 1,500 professionals in the vaccine industry, creating opportunities for hundreds of networking hours.

World Vaccine Congress Washington will explore the complete vaccine value chain.

Key visitors will include government officials, academia, and leading pharma, biotech and small-to-medium-sized enterprise (SME) biotech companies.

Progressive, scientific and strategic solutions for the vaccine industry

World Vaccine Congress Washington delivers a platform where global pharmaceutical service providers and their partners can discuss scientific, clinical and strategic advances and opportunities.

The event has confirmed more than 200 speakers, including representatives from the Merck, the World Health Organization (WHO), Glaxo Smith Klein (GSK) and the National Institute of Health (NIAID).

Global Vaccine Leaders speaking at the event include members of the US the Food and Drug Administration (FDA) and the United States Department of Agriculture (USADA), as well as representatives of companies such as Janssen, Merck Vaccines, Pfizer and Sanofi. Speakers will also be present from schools, including Kinshasa University Medical School, University of Pennsylvania School of Medicine & Vaxconsult, and University of Maryland School of Medicine.

Networking opportunities worldwide

The World Vaccine Congress provides the occasion to hear from more than 350 senior speakers across the spectrum of the vaccine market.

We will have government representatives from WHO, CEPI, European Commission, EMA, FDA to C-level executives from GSK, Merck, Pfizer, Janssen, Sanofi amongst many others.

With more than 1,500 attendees expected, this is a great chance to meet and network with hundreds of like-minded peers at the biggest vaccines meeting in the world.

Attend focused sessions across multiple tracks and ten co-located conferences covering topics from respiratory infections, emerging and infectious diseases, cancer immunotherapy, immune profiling, supply and logistics, manufacture, clinical development, veterinary vaccines, vaccine partnerships and many more.

This year, there will be more networking opportunities than ever, as throughout the three days’ worth of content there are extended breaks and multiple drinks receptions, giving you more time to meet cross-sector contacts.

Interactive workshops to explore the pharmaceutical and biotech industry topics

Similar to the conference itself, the pre-congress workshops will cover a range of topics, including animal health, cancer, adjuvants, antimicrobial resistance and many others.

Some examples of workshops include:

  • Bridging the gap between human and animal cancer: translational studies of a polyvalent cancer penetrative vaccine. Dr Douglas H Thamm, Professor of Oncology, Director of Clinical Research, Flint animal Center
  • Vaccine Uptake and Cost-sharing in the Medicare Population. Philip Buck, PhD, MPH, Head, US, Health Outcomes, Vaccines, GSK
  • Identification of immune signatures of novel adjuvant formulations using machine learning. Dr Elke S Bergmann-Leitner, Malaria Vaccine Branch, US Military Malaria Research Program, Walter Reed Army Institute of Research
  • A regulatory perspective on NGS for adventitious virus detection in biologics Dr Arifa Khan, Principal Investigator/Supervisory Microbiologist in the Division of Viral Products, CBER, FDA
  • Rapid response – from discovery to clinical trials Dr Chris Earnhart, Joint Product Lead, PRISM – Platforms for Rapid Integrated Solutions for Medical Countermeasures, Medical Countermeasure Systems, US Army
  • Applications of structural bioinformatics in vaccine design Dr Gwo-Yu Chuang, Co-Head and Staff Scientist of the Structural Bioinformatics Core Section, NIH

Thought leadership presentations, panel discussions and exhibition stands

Throughout World Vaccine Congress Washington, companies will be delivering their key messages at thought leader presentations on a chosen topic. These include panel discussions, roundtables, branding promotions, case study presentations, technology showcases.

Exhibition stands also provide companies with access to vaccine industry decision-makers.

Find out more and download the 2020 agenda: www.terrapinn.com/WVCDC/PBR-agenda

or

Visit the site:
www.terrapinn.com/WVCDC/PBR-home

Contact details

Walter E Washington Congress Center
801 MT Vernon PI NW,
20001 Washington DC
United States

Quick Contact World Vaccine Congress


Top Products from World Vaccine Congress

Quick Contact World Vaccine Congress
Quick Contact World Vaccine Congress
Quick Contact World Vaccine Congress


Quick Contact World Vaccine Congress
Quick Contact World Vaccine Congress
Quick Contact World Vaccine Congress


Contact World Vaccine Congress

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.

Confirmation

Finally, complete a quick security check and confirm terms and conditions:

Quick Contact World Vaccine Congress